10x Genomics, Inc. (TXG)
NASDAQ: TXG · IEX Real-Time Price · USD
37.53
+0.64 (1.73%)
At close: Mar 28, 2024, 4:00 PM
37.44
-0.09 (-0.24%)
After-hours: Mar 28, 2024, 7:53 PM EDT
10x Genomics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for 10x Genomics stock have an average target of 60.3, with a low estimate of 30 and a high estimate of 75. The average target predicts an increase of 60.67% from the current stock price of 37.53.
Analyst Consensus: Buy
* Price targets were last updated on Feb 16, 2024.
Analyst Ratings
The average analyst rating for 10x Genomics stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 5 | 4 | 4 | 4 |
Buy | 4 | 4 | 5 | 5 | 5 | 5 |
Hold | 1 | 1 | 2 | 2 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Total | 10 | 10 | 13 | 12 | 11 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Strong Buy Maintains $68 → $63 | Strong Buy | Maintains | $68 → $63 | +67.87% | Feb 16, 2024 |
Barclays | Barclays | Buy Maintains $45 → $55 | Buy | Maintains | $45 → $55 | +46.55% | Jan 25, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +59.87% | Dec 14, 2023 |
Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 13, 2023 |
B of A Securities | B of A Securities | Sell → Hold Upgrades $36 → $54 | Sell → Hold | Upgrades | $36 → $54 | +43.88% | Dec 12, 2023 |
Financial Forecast
Revenue This Year
685.67M
from 618.73M
Increased by 10.82%
Revenue Next Year
803.67M
from 685.67M
Increased by 17.21%
EPS This Year
-1.63
from -2.18
EPS Next Year
-0.95
from -1.63
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 719.8M | 906.2M | 1.1B | 1.3B | 1.5B |
Avg | 685.7M | 803.7M | 941.3M | 1.2B | 1.4B |
Low | 658.9M | 729.0M | 813.4M | 1.2B | 1.4B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 16.3% | 32.2% | 35.9% | 33.2% | 20.4% |
Avg | 10.8% | 17.2% | 17.1% | 28.1% | 15.8% |
Low | 6.5% | 6.3% | 1.2% | 24.4% | 12.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.17 | -0.35 | 0.72 | 2.77 | 3.54 |
Avg | -1.63 | -0.95 | -0.19 | 2.67 | 3.40 |
Low | -2.25 | -1.45 | -1.10 | 2.59 | 3.30 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 32.7% |
Avg | - | - | - | - | 27.7% |
Low | - | - | - | - | 23.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.